STAR — Strides Pharma Science Income Statement
0.000.00%
Last trade - 00:00
- IN₹77.48bn
- IN₹100.50bn
- IN₹36.88bn
- 64
- 18
- 99
- 68
C2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21,784 | 27,520 | 33,159 | 30,703 | 36,884 |
Cost of Revenue | |||||
Gross Profit | 9,747 | 14,695 | 17,972 | 13,672 | 18,567 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20,076 | 24,555 | 28,766 | 36,071 | 35,615 |
Operating Profit | 1,708 | 2,965 | 4,393 | -5,368 | 1,269 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 624 | 547 | 2,754 | -6,525 | -2,862 |
Provision for Income Taxes | |||||
Net Income After Taxes | 893 | 434 | 2,438 | -4,743 | -2,309 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,246 | 364 | 2,684 | -4,602 | -2,026 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,246 | 364 | 2,684 | -4,602 | -2,026 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.62 | 12.8 | 27 | -30.4 | -23.6 |
Dividends per Share |